Stay updated on Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Access to the study record for NCT03332498 now displays a 403 Forbidden error page, replacing the previous content that described the study. This indicates the page is currently blocked or unavailable, preventing viewing the study details on ClinicalTrials.gov.
    Difference
    18%
    Check dated 2026-09-19T20:52:28.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.6 from v3.6.5, indicating a backend/template update; no study content or participant information appears to be changed.
    Difference
    0.1%
    Check dated 2026-08-29T20:48:22.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a minor maintenance/metadata update rather than a change to core study content.
    Difference
    0.1%
    Check dated 2026-08-08T18:59:03.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, indicating a new version of the study record. This change is administrative and does not alter the study details or participant-facing information.
    Difference
    0.1%
    Check dated 2026-07-25T10:41:11.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Footer area now includes new institutional attributions for the Moffitt Cancer Center Clinical Trials website and related entities, and the revision tag in the footer has been updated from v3.6.2 to v3.6.3.
    Difference
    0.2%
    Check dated 2026-07-03T22:53:27.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a recent deployment of the ClinicalTrials.gov page. This update does not change the study details or any data presented on the page.
    Difference
    0.1%
    Check dated 2026-06-26T23:21:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.